Experience. Integrity. IMPACT.
What We Do

IMPACT’S Making an IMPACT Initiative Celebrates 2020

RESEARCH TRIANGLE PARK, NC: 10 February 2021 – In 2020, IMPACT’s employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. The past year provided us opportunities to connect with various charities virtually, support various disaster and pandemic relief efforts, and encourage our community with cards and random acts of kindness.

Australia Bushfire Relief Fundraisers

In January, MAI supported fundraisers for the New South Wales Rural Fire Service and the Kangaroo Island Wildlife Park to highlight these great causes that protected and provided for the people and animals displaced and injured by the Australian bushfires.

Together, we raised over $1,450 AUD! Thank you to everyone who donated to these charitable organizations!

Valentine’s Day

In February, to celebrate Valentine’s Day and to spread some love through the office, the MAI team put together goodie bags for everyone in the office.

In addition to candies and a handwritten note, each employee was surprised with a glass etched with funny writing-related sayings. One of the favorites was: “Let’s eat kids. Let’s eat, kids. Use a comma. Save lives!”.

Continue reading

IMPACT Expands Management Team in Medical Writing Services

RESEARCH TRIANGLE PARK, NC: 09 November 2020 – At IMPACT our core purpose is to develop and inspire pharmaceutical professionals.  We understand the importance of what we do.  By providing high quality medical writing and regulatory services to our pharma and biotech clients, we have the potential to accelerate the development of promising new therapies – new therapies that will have a positive impact on the quality of the lives of countless patients.  And we believe that we can only do what we do well when we attract, nurture, and retain the best and the brightest drug development professionals.  In other words, inspiring and developing pharmaceutical professionals is the focus that propels us to serve our clients, and therefore the patients that our clients serve, with unwavering excellence.

Continue reading

IMPACT Announces Formation of Executive Leadership and Leadership Teams

RESEARCH TRIANGLE PARK, NC: 02 November 2020 – In the first half of 2020, IMPACT’s Chief Executive Officer (CEO), Mark Cierpial, PhD, led the company in a comprehensive review of the organization’s health.  The goal of this review was to gain insight and information to set the foundation for strategic planning and operational decision making in the coming years.  The review started with a company-wide Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis, which led to deeper discussions about IMPACT’s core purpose and values.  As discussions unfolded, a clearer, more specific answer to the question, “Why does IMPACT exist?” emerged, and a reconceived core purpose was articulated.

Continue reading

Holly Buchanan, M.S., RAC, Promoted to Principal Consultant

RESEARCH TRIANGLE PARK, NC: 23 September 2020 – In March 2020, Holly Buchanan, M.S., RAC, was promoted to the position of Principal Consultant at Impact Pharmaceutical Services, Inc. (IMPACT).

Holly joined IMPACT in 2017 with over 15 years of medical writing, regulatory, and program management experience within CRO and pharmaceutical environments. Holly’s experience ranges from early to late phase drug development, with her most recent experiences being on original marketing applications, as well as line extensions and responses to regulatory agency questions. Holly is an excellent reviewer who embraces our commitment to a culture of learning, serving as a mentor to many of our more junior medical writers and fostering their career development.

Continue reading

Rebecca Pogue, PhD, Promoted to Consultant

RESEARCH TRIANGLE PARK, NC: 23 September 2020 – In February 2020, Rebecca Pogue, PhD, was promoted to the position of Consultant at Impact Pharmaceutical Services, Inc. (IMPACT).

Rebecca joined IMPACT in October 2017 with over 10 years of medical writing experience within CRO and pharmaceutical environments, having worked on numerous types of early and late phase regulatory documents. Since joining IMPACT, Rebecca has continued working on an increasing breadth and complexity of documents, including pivotal CSRs (many with complex statistical plans), briefing documents, marketing application submission components, and responses to regulatory agency questions. In addition, as one of our senior reviewers, Rebecca has been praised for her willingness to take the time to teach and mentor her colleagues, ensuring they understand both the scientific and regulatory aspects of their projects.

Continue reading